Thomas Unger

Thomas Unger

THE NETHERLANDS

 

 

 

 

As of April 1st, 2012 Professor Thomas Unger is Scientific Director of CARIM – School for Cardiovascular Diseases at the Maastricht University. Before this Professor Thomas Unger held the Chair of Pharmacology and was Director of the Institute of Pharmacology and of the Center for Cardiovascular Research (CCR) at the Charité – Universitätsmedizin Berlin until March 2012. Professor Unger is also Chairman of the German Institute for High Blood Pressure Research in Berlin (DIB). Between 1994 and 2001, he was Director of the Institute of Pharmacology at the University of Kiel, Germany. Professor Unger studied medicine in Germany and the UK, and gained his MD from the University of Heidelberg, Germany. He then carried out postdoctoral research at the Clinical Research Institute of Montreal, Canada, and the Department of Pharmacology in Heidelberg, where he received his PhD in Pharmacology. Until 1994, Professor Unger held professorships in pharmacology and hypertension research at the University of Heidelberg. In recognition of his work, Professor Unger has received the German Hypertension Society´s Franz Gross Award for Hypertension Research, the Meilahti Lecture Award of the Medical Faculty, University of Helsinki, Finland, the Björn Folkow Award of the European Society of Hypertension, and the Robert Tigerstedt Award of the Finnish Hypertension Society. Professor Unger is vice chair of Berlin-Brandenburg Cardiovascular Society and a member of the German Societies of Pharmacology, Cardiology and Hypertension (Council Member 1995–2001), the International Society of Hypertension, the European Society of Hypertension (Council Member 1989–97), the European Council for Blood Pressure and Cardiovascular Research (President, 2000–2), the Inter-American Society of Hypertension, He is Honorary Member of the British, Finnish and Italian Hypertension Society and a Fellow of the European Society of Cardiology and the American Heart Association. Professor Unger has authored more than 700 scientific publications. He is or has been a member of the Editorial Boards of the American Journal of Physiology, American Journal of Hypertension, Biochemical Pharmacology, Blood Pressure, Cardiovascular Drugs and Therapy, Clinical and Experimental Hypertension, Hypertension, Hypertension Research, Journal of Hypertension, Fundamental and Clinical Pharmacology, Physiological Genomics, Regulatory Peptides, High Blood Pressure & Cardiovascular Prevention.